(Q36173170)

English

Prediction of BRCA1 germline mutation status in women with ovarian cancer using morphology-based criteria: identification of a BRCA1 ovarian cancer phenotype

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Prediction of BRCA1 germline mutation status in women with ovarian cancer using morphology-based criteria: identification of a BRCA1 ovarian cancer phenotype (English)

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Alice S. Whittemore

5

object named as

Alice S Whittemore

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

4

object named as

Weiva Sieh

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

author name string

Mika Fujiwara

1

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Valerie A McGuire

2

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Anna Felberg

3

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Teri A Longacre

6

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

language of work or name

0 references

publication date

1 August 2012

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

The American Journal of Surgical Pathology

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

36

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

8

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

1170-1177

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

BRCA1/2 mutations and triple negative breast cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422129

1 October 2017

Pathology of hereditary breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422129

1 October 2017

The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422129

1 October 2017

Multistep level sections to detect occult fallopian tube carcinoma in risk-reducing salpingo-oophorectomies from women with BRCA mutations: implications for defining an optimal specimen dissection protocol

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422129

1 October 2017

The prevalence of BRCA1 mutations among young women with triple-negative breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422129

1 October 2017

A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422129

1 October 2017

A review of histopathological subtypes of ovarian cancer in BRCA-related French Canadian cancer families.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422129

1 October 2017

Hereditary ovarian cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422129

1 October 2017

Pathology of ovarian cancers in BRCA1 and BRCA2 carriers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422129

1 October 2017

The pathology of inherited breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422129

1 October 2017

Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422129

1 October 2017

Histopathology of familial ovarian tumors in women from families with and without germline BRCA1 mutations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422129

1 October 2017

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422129

1 October 2017

Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422129

1 October 2017

Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422129

23 September 2018

Histopathological criteria and selection algorithms for BRCA1 genetic testing.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422129

23 September 2018

Serous tubal intraepithelial carcinoma and the dominant ovarian mass: clues to serous tumor origin?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422129

23 September 2018

Morphology of breast cancer as a means of triage of patients for BRCA1 genetic testing.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422129

23 September 2018

Relation of contraceptive and reproductive history to ovarian cancer risk in carriers and noncarriers of BRCA1 gene mutations.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422129

23 September 2018

BRCA germline mutations in Jewish women with uterine serous papillary carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422129

23 September 2018

Histopathology, FIGO stage, and BRCA mutation status of ovarian cancers from the Gilda Radner Familial Ovarian Cancer Registry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422129

23 September 2018

Toward the development of a universal grading system for ovarian epithelial carcinoma: testing of a proposed system in a series of 461 patients with uniform treatment and follow-up.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422129

23 September 2018

“BRCAness” Syndrome in Ovarian Cancer: A Case-Control Study Describing the Clinical Features and Outcome of Patients With Epithelial Ovarian Cancer Associated WithBRCA1andBRCA2Mutations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422129

5 December 2018

Society of Gynecologic Oncologists Education Committee Statement on Risk Assessment for Inherited Gynecologic Cancer Predispositions☆

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3422129

5 December 2018

Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status

1 reference

https://pubmed.ncbi.nlm.nih.gov/22790858

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Unexpected gynecologic neoplasms in patients with proven or suspected BRCA-1 or -2 mutations: implications for gross examination, cytology, and clinical follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/22790858

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mutation analysis of BRCA1, TP53, and KRAS2 in ovarian and related pelvic tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/22790858

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Major improvement in the efficacy of BRCA1 mutation screening using morphoclinical features of breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22790858

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinicopathologic features of BRCA-linked and sporadic ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22790858

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Histopathologic features of genetically determined ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22790858

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Grading ovarian serous carcinoma using a two-tier system

1 reference

https://pubmed.ncbi.nlm.nih.gov/22790858

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hereditary ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22790858

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The genetic attributable risk of breast and ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22790858

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium

1 reference

https://pubmed.ncbi.nlm.nih.gov/22790858

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations: a population-based study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22790858

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recommendations for the reporting of fallopian tube neoplasms

1 reference

https://pubmed.ncbi.nlm.nih.gov/22790858

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1097/PAS.0B013E31825D9B8D

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36173170&oldid=1713370732"